Xiaoqing Zhou

机构：Beijing University of Chinese Medicine, Gannan Medical University, Jining First People's Hospital · ORCID：0000-0002-4370-6244

发表论文 38 篇 · 总被引 503 次 · h-index 12

代表论文

• Genetically engineered pigs for xenotransplantation: Hopes and challenges (2023 · Frontiers in Cell and Developmental Biology · 被引 46)
• Niclosamide Inhibits Cell Growth and Enhances Drug Sensitivity of Hepatocellular Carcinoma Cells via STAT3 Signaling Pathway (2018 · Journal of Cancer · 被引 43)
• Knockdown of miR-222 inhibits inflammation and the apoptosis of LPS-stimulated human intervertebral disc nucleus pulposus cells (2019 · International Journal of Molecular Medicine · 被引 42)
• The mitochondrial regulation in ferroptosis signaling pathway and its potential strategies for cancer (2023 · Biomedicine & Pharmacotherapy · 被引 34)
• RO7049389, a core protein allosteric modulator, demonstrates robust anti-HBV activity in chronic hepatitis B patients and is safe and well tolerated (2018 · Journal of Hepatology · 被引 24)
• Immunity and inflammation predictors for short-term outcome of stroke in young adults (2017 · International Journal of Neuroscience · 被引 24)